- Home
- AVIR vs PKBK Comparison
AVIR vs PKBK Comparison
Compare AVIR & PKBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- PKBK
- Stock Information
- Founded
- AVIR 2012
- PKBK 1999
- Country
- AVIR United States
- PKBK United States
- Employees
- AVIR N/A
- PKBK N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- PKBK Major Banks
- Sector
- AVIR Health Care
- PKBK Finance
- Exchange
- AVIR Nasdaq
- PKBK Nasdaq
- Market Cap
- AVIR 277.8M
- PKBK 256.4M
- IPO Year
- AVIR 2020
- PKBK N/A
- Fundamental
- Price
- AVIR $3.50
- PKBK $21.40
- Analyst Decision
- AVIR Hold
- PKBK
- Analyst Count
- AVIR 1
- PKBK 0
- Target Price
- AVIR $6.00
- PKBK N/A
- AVG Volume (30 Days)
- AVIR 361.0K
- PKBK 24.1K
- Earning Date
- AVIR 08-07-2025
- PKBK 07-16-2025
- Dividend Yield
- AVIR N/A
- PKBK 3.36%
- EPS Growth
- AVIR N/A
- PKBK 42.58
- EPS
- AVIR N/A
- PKBK 2.56
- Revenue
- AVIR N/A
- PKBK $66,879,999.00
- Revenue This Year
- AVIR N/A
- PKBK N/A
- Revenue Next Year
- AVIR N/A
- PKBK N/A
- P/E Ratio
- AVIR N/A
- PKBK $8.35
- Revenue Growth
- AVIR N/A
- PKBK 3.52
- 52 Week Low
- AVIR $2.46
- PKBK $16.94
- 52 Week High
- AVIR $4.15
- PKBK $24.29
- Technical
- Relative Strength Index (RSI)
- AVIR 48.71
- PKBK 53.93
- Support Level
- AVIR $3.33
- PKBK $20.36
- Resistance Level
- AVIR $3.60
- PKBK $22.24
- Average True Range (ATR)
- AVIR 0.16
- PKBK 0.59
- MACD
- AVIR -0.02
- PKBK 0.05
- Stochastic Oscillator
- AVIR 26.69
- PKBK 62.33
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.